Health

In a Forbes opinion piece, Joseph Coughlin, director of the MIT AgeLab, emphasizes the importance of place planning, which includes factoring climate risks in retirement decisions, and considering whether a community will work for an individual in the future. “If where we live increasingly shapes our health, mobility, access to care, social connection, and resilience, then retirement planning needs another dimension beyond financial preparedness,” writes Coughlin. “It is no longer simply, ‘Is this where I want to grow old?’ It is, ‘Will this place continue to support me as I grow older?’"

Jay Fox of the Ohio News Network joins Ohio 10 WBNS to discuss his conversation with President Sally Kornbluth about how life-changing scientific innovations in university research labs have helped build our nation’s technological prowess and ensured our strength and stability, explaining how federal research cuts threaten future medical and technological advances. “What’s at risk are the kind of cures and technological advances that we’ll enjoy as we age, as our children get older and their children’s children get older. It’s really the future that is being mortgaged at this point,” said Kornbluth during her discussion with Fox. 

MIT President Sally Kornbluth and Arizona State University President Michael Crow joined forces for a spirited discussion moderated by Washington Post reporter Zachary Goldfarb on the importance of curiosity-driven research, examining how universities are preparing the next generation of scientists to lead in America’s rapidly changing technological landscape. “Many of the things we have in our everyday lives, whether they be medical advances, technological advances, a lot of these things came from 30, 40, 50 years of scientists just trying to figure out how things work,” said Kornbluth. 

New York Times reporters Gina Kolata and Rebecca Robbins highlight how university researchers at MIT and Harvard laid the groundwork for the development of a new treatment for pancreatic cancer that “could wind up being the most significant advance in cancer treatment in 15 years, since the arrival of immunotherapy.” They write: “In 1982, Robert Weinberg, a scientist at MIT, made one of the seminal discoveries about how RAS genes fuel some cancers.” 

Two new studies from researchers at MIT and elsewhere have described “the machine-learning algorithms they developed to screen bacterial genomes and identify proteins that are involved in protecting the microorganisms against viral invaders,” reports Miryam Naddaf for Nature. “There’s a hope that maybe there’s a next generation of molecular tools that would come from some of these new systems,” says Prof. Michael Laub. 

Writing for Forbes, Senior Lecturer Guadalupe Hayes-Mota 08, SM '16, MBA '16 explores how businesses can best prepare for the rapid advancements underway in the field of neurotechnology. “I believe that one of the most important steps companies can take regarding this emerging technology is to act now, without waiting for regulatory clarity first,” writes Hayes-Mota. “Treat neural data as categorically sensitive from day one—not because you are forced to, but because you understand that operating this close to the human mind demands a higher threshold of trust than almost any technology before it.” 

Prof. Pat Pataranutaporn speaks with The Guardian reporter Andrew Gregory about the lack of safety warnings and disclaimers in AI overviews, specifically in AI-generated health materials. “The absence of disclaimers when users are initially served medical information creates several critical dangers,” says Pataranutaporn. “Disclaimers serve as a crucial intervention point. They disrupt this automatic trust and prompt users to engage more critically with the information they receive.”

A new study by researchers at MIT and elsewhere has found a correlation between addiction and eye care, reports Hadley Barndollar for MassLive. “The study found nearly half of the patients with opioid use disorder being treated for the eye infection were eligible to initiate medication-assisted treatment,” explains Barndollar. “But medications were only initiated when an addiction consult occurred, highlighting how much more eye doctors responding to emergency rooms can offer patients beyond vision care.” 

Senior Research Scientist Leo Anthony Celi speaks with New York Times reporter Gina Kolata about the use of AI in health care. “The real concern isn’t AI itself,” says Celi. “It’s the AI is being deployed to optimize a profoundly broken system rather than to reimagine it.” 

Prof. Marzyeh Ghassemi and Monica Agrawal PhD '23 speak with Boston Globe reporter Hiawatha Bray about the risks on relying solely on AI for medical information. “What I’m really, really worried about is economically disadvantaged communities,” says Ghassemi. “You might not have access to a health care professional who you can quickly call and say, ‘Hey… Should I listen to this?’”  

In an appearance on the national "Diabetics Doing Things" podcast, MIT President Sally Kornbluth and Johns Hopkins University President Ron Daniels discuss their experience as Type 1 diabetics, the importance of scientific research to diagnoses and treatments that have impacted millions of fellow Type 1 diabetics across the country, and the impact on their own lives of decades of advances made at leading research universities like theirs. In conversation with host Rob Howe, they reflect on the salience of standing up for the scientific enterprise. 

Prof. Lonnie Petersen speaks with Benjamin Rachlin, executive editor of MIT Horizon, about the future of space medicine in an article for The Boston Globe. “The next generation of flight surgeons might work from orbit. They might accompany a crew on a long-term mission, like a medic with a platoon,” writes Rachlin. “There is no standard yet for medical care in space. Doctors are inventing it.” Petersen notes that: “Space is like New York. If you can make it there, you can make it anywhere.”

MassLive reporter Scott Kirsner spotlights Claire Beskin MBA '22, CEO and founder of Empallo, a virtual clinic for heart care aimed at preventing cardiac issues before they happen. “It handles everything from scheduling to prescriptions to billing,” writes Kirsner. “Empallo’s approach, Beskin said, is ‘virtual first,’ meaning it tries to give patients an online consult with a doctor when possible, and send them into the office when necessary.” 

Prof. Jonathan Gruber speaks with David Frum from The Atlantic’s “The David Frum Show” to shed light on the American healthcare system and health care disparities. “The issue in the U.S. is there are the haves and the have-nots—the haves get comparable health care to the rest of the world at a much higher price; the have-nots get worse health care at a much higher price,” says Gruber. “There’s really two fundamental challenges in U.S. health care: There’s disparities, and there’s costs.” 

Prof. Hugh Herr speaks with Bloomberg Businessweek Daily host Carol Massar and Tim Stenovec about his work creating bionic limbs that combine human physiology with electromechanics. “I really realized how limited the current prosthetic technology was and I dedicated my life as a young man to really advance the field and enable extraordinary technology that will allow people to do what they want again, to move again and have the bodies that they seek," says Herr.